Want to join the conversation?
$AVGO 2Q15 10-Q: Revenue was $1,614MM vs. $701MM in 2Q14. Cost of products sold was $768MM vs. $344MM in 2Q14. Gross margin was $846MM vs. $357MM in 2Q14. Operating expenses were $428MM vs. $197MM in 2Q14. Operating income was $418MM vs. $160MM in 2Q14. Net income was $344MM vs. $158MM in 2Q14. Diluted earnings per share $1.21 vs. $0.61 in 2Q14.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)